news
Sustained-release chemotherapy has potential for bladder cancer
A study has shown an intravesical sustained-release chemotherapy device demonstrated effectiveness in advanced bladder cancer.
List view / Grid view
Mayo Clinic
news
COVID-19 antibody therapies safe and effective for transplant patients
Monoclonal antibody therapies found to reduce progression to severe disease, risk of hospitalisation and death in transplant recipients with mild to moderate COVID-19.
news
Novel ionic liquid enables uniform chemotherapy delivery in solid tumours
Co-injecting doxorubicin with LATTE, a novel ionic liquid formulation, resulted in uniform chemotherapy delivery and successful ablation in solid tumours.
news
Artificial intelligence used to detect early-stage heart disease
Mayo study uses artificial intelligence to create inexpensive, widely available early detector of heart disease...
news
Oxybutynin improves quality of life for breast cancer survivors
Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life...
news
Watson system increases clinical trial enrolment by 80 percent
Watson for Clinical Trial Matching, an AI platform, has shown an increase of 80 percent in enrolment for breast cancer clinical trials, along with reduced screening times for patients...
news
Mouse model shows success of senolytic drugs in reversing senescent cell damage
An NIH-funded study has demonstrated that a combination of senolytic drugs can successfully reverse cell senescence in mice; providing potential avenue for future age-related treatment study.
news
DNA test may detect liver cancer
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer....
news
Study reveals huge improvement for severe HHT patients after bevacizumab treatment
A new study reveals the efficacy and safety of using intravenous bevacizumab to treat patients with severe hereditary haemorrhagic telangiectasia (HHT). Successful results suggest it should be used as a first-line therapy.
news
Tolvaptan identified as a treatment for autosomal dominant polycystic kidney disease
A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with polycystic kidney disease...
news
Proton therapy may be better option for patients with esophageal cancer
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
news
Z-endoxifen shows promise for breast cancer
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
